Back to BlackRock, Inc. BlackRock, Inc.

CTNMCTNM
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CONTINEUM THERAPEUTICS INC

BlackRock, Inc. holds 2.1M shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $33.8M as of 2026-Q2. The position was increased (+208.5% shares). CTNM represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$33.8M

Current Shares

2.1M

Total Value Change

+$25M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+208.5%
$33.8M0.0%$16.39
47
2026-Q1
Increased
669,123
+24.8%
$8.7M0.0%$14.10
34
2025-Q4
Increased
536,155
+66.5%
$6.1M0.0%$11.40
40
2025-Q3
Increased
322,031
+94.6%
$3.8M0.0%$11.82
42
2025-Q2
Decreased
165,446
-73.2%
$656,8210.0%$4.11
0
2025-Q1
Increased
616,624
+2.2%
$4.3M0.0%$7.07
27
2024-Q4
New
603,577
-
$8.8M0.0%$14.47
38

Other major holders of CTNM: Janus Henderson Group Ltd., FRANKLIN RESOURCES INC, BALYASNY ASSET MANAGEMENT L.P., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used